← Back to Search

EMMA App + Clinician Support for Cognitive Impairment (EMMA Trial)

N/A
Recruiting
Led By Maureen Schmitter-Edgecombe, PhD
Research Sponsored by Washington State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline and 6 month follow-up
Awards & highlights

EMMA Trial Summary

This trial studies an app-based system to help older adults with memory & daily activity management. It asks if clinician oversight is needed for use of the app.

Who is the study for?
This trial is for older adults aged 50 or above who feel they have memory issues but can still read and speak English. It's not suitable for those with severe vision or hearing problems, unable to consent, or have a medical condition like stroke explaining their cognitive complaints.Check my eligibility
What is being tested?
The study tests a web-based training program teaching the use of an app called EMMA, designed to help with memory and daily tasks. The role of clinician support in learning to use this app effectively will also be assessed.See study design
What are the potential side effects?
Since this intervention involves using an application and web-based training, side effects are minimal but may include discomfort from prolonged screen time or frustration if difficulties arise while learning the technology.

EMMA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline and 6 month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline and 6 month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Cognitive Self-efficacy Questionnaire (CSEQ)
Change in Daily Assessment of Independent Living and Executive Skills (DAILIES)
Change in EMMA app use daily interactions
+1 more
Secondary outcome measures
Change in Coping Self-efficacy Scale (CSES)
Change in Everyday Compensation questionnaire (Ecomp)
Change in Patient-Reported Outcome Measurement Information (PROMIS) System Applied Cognition
+1 more

EMMA Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Brief Clinician Motivational SupportExperimental Treatment2 Interventions
Participants will learn to use the EMMA app through a personalized web-based training platform with brief weekly motivational support from a clinician.
Group II: Technology Support OnlyActive Control1 Intervention
Participants will learn to use the EMMA app through a personalized web-based training platform with technical support and reminders as needed.

Find a Location

Who is running the clinical trial?

Washington State UniversityLead Sponsor
101 Previous Clinical Trials
56,664 Total Patients Enrolled
United States Department of DefenseFED
865 Previous Clinical Trials
327,649 Total Patients Enrolled
Maureen Schmitter-Edgecombe, PhDPrincipal InvestigatorWashington State University
1 Previous Clinical Trials
30 Total Patients Enrolled

Media Library

Personalized Web-based training for EMMA app Clinical Trial Eligibility Overview. Trial Name: NCT05696756 — N/A
Mild Cognitive Impairment Research Study Groups: Technology Support Only, Brief Clinician Motivational Support
Mild Cognitive Impairment Clinical Trial 2023: Personalized Web-based training for EMMA app Highlights & Side Effects. Trial Name: NCT05696756 — N/A
Personalized Web-based training for EMMA app 2023 Treatment Timeline for Medical Study. Trial Name: NCT05696756 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still capacity to recruit participants for this research?

"This clinical trial is still enrolling volunteers, as per the information on clinicaltrials.gov. It was initially posted on the 20th of January in 20203 and last modified a little over two weeks ago, on January 13th."

Answered by AI

How many individuals are involved in participating in this investigation?

"Affirmative. According to clinicaltrials.gov, the trial in question is still trying to attract participants and was initially posted on January 20th of 2023 with a recent update made on January 13th of that same year. The investigators are looking for 50 individuals from one particular medical facility."

Answered by AI

What primary objectives are researchers attempting to achieve through this experiment?

"The primary measure of success in this trial, which will be tracked over the 6-month duration to study completion, is Change in Daily Assessment of Independent Living and Executive Skills (DAILIES). Additionally, investigators are tracking Change in Everyday Compensation questionnaire (Ecomp), Change in Patient-Reported Outcome Measurement Information (PROMIS) System Applied Cognition scores, as well as a change in Self-Efficacy for Appropriate Medication Use Scale (SEAMS) score."

Answered by AI

Who else is applying?

What site did they apply to?
Washington State University - Pullman; Study Remote
What portion of applicants met pre-screening criteria?
Did not meet criteria

Why did patients apply to this trial?

I like doing trials.
PatientReceived no prior treatments
Recent research and studies
clinicaltrials.govStudy
Electronic Memory and Management Aid
Maureen-Schmitter-Edgecombe 2023. "Electronic Memory and Management Aid". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05696756.
All > Health > Spokane
~0 spots leftby May 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top